LISSONI ANDREA ALBERTO

Marino, G., Grassi, T., De Ponti, E., Negri, S., Testa, F., Giuliani, D., et al. (2024). Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy. FRONTIERS IN ONCOLOGY, 14 [10.3389/fonc.2024.1330481]. Dettaglio

Cordani, N., Bianchi, T., Ammoni, L., Cortinovis, D., Cazzaniga, M., Lissoni, A., et al. (2023). An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(15) [10.3390/ijms241511890]. Dettaglio

Colombo, N., Gadducci, A., Landoni, F., Lorusso, D., Sabbatini, R., Artioli, G., et al. (2023). Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study. GYNECOLOGIC ONCOLOGY, 175(August 2023), 182-189 [10.1016/j.ygyno.2023.05.065]. Dettaglio

Adorni, M., Bazzurini, L., Lissoni, A., Vecchione, F., Negri, S., Grassi, T., et al. (2022). Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience. TUMORI, 108(5), 495-501 [10.1177/03008916211027627]. Dettaglio

Colombo, N., Tomao, F., Benedetti Panici, P., Nicoletto, M., Tognon, G., Bologna, A., et al. (2022). Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY, 164(3), 505-513 [10.1016/j.ygyno.2022.01.015]. Dettaglio